Health
15 Oct 2026
New CAR T‑cell therapy shows early promise for relapsed B‑cell cancers
A first‑in‑human study of a trispecific CAR T‑cell therapy that also uses OX‑40 shows encouraging results in patients with relapsed B‑cell blood cancers.
Read more